At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Novel Biomarkers of Erythropoietin Resistant Anemia Among Patients With Chronic Kidney Disease
In Brief
An observational study for Anemia and 2 related conditions. Completed, enrolled 32 participants across 2 sites.
Detailed Summary
Our goal of this pilot project is to identify inflammatory biomarkers that correlate with epo-resistance among CKD patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia, Kidney Failure, Erythropoietin
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
First PostedSep 2007
Primary CompletionJun 2008
TodayJul 2026
First PostedSep 10, 2007
Enrollment StartAug 1, 2007
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 18.8 years ago